Yeongjoon Gil
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yeongjoon Gil has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Dae In Kim
Department of Internal Medicine Seoul National University Bundang Hospital Seongnam Korea
1 shared publication - Hyejin Lee
Department of Family Medicine, Seoul National University Bundang Hospital
1 shared publication - Il-Young Oh
Cardiovascular Center, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
1 shared publication - Jeong Yeon Kwak
Department of Internal Medicine Seoul National University Bundang Hospital Seongnam Korea
1 shared publication - Ji Hyun Lee
Department of Cardiology, Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam, Korea
1 shared publication - Joo Yeon Yoo
Department of Internal Medicine Seoul National University Bundang Hospital Seongnam Korea
1 shared publication
Latest Publications
- Open Access
- 8 May 2023
- Published by Wiley in Journal of Arrhythmia
- Vol. 39 (3) , 422-429
The efficacy of detecting arrhythmia is higher with 7‐day continuous electrocardiographic patch monitoring than with 24‐h Holter monitoring
Background: Detecting high‐risk arrhythmia is important in diagnosing patients with palpitations. We compared the diagnostic accuracies of 7‐day patch‐type electrocardiographic (ECG) monitoring and 24‐h Holter monitoring for detecting significant arrhythmias in patients with palpitations.Methods: This was a single‐center prospective trial with 58 participants who presented with palpitations, chest pain or syncope. Outcomes were defined as the detection of any one of six arrhythmias, including supraventricular tachycardia (SVT), atrial fibrillation or atrial flutter lasting more than 30 s, pauses of more than 3 s, high‐degree atrioventricular block, ventricular tachycardia (VT) >3 beats, or polymorphic VT/ventricular fibrillation. The McNemar test for paired proportions was used to compare arrhythmia detection rates.Results: The overall arrhythmia detection rate was higher with 7‐day ECG patch monitoring than with 24‐h Holter monitoring (34.5% vs. 19.0%, p = .008). Compared with the use of 24‐h Holter monitors, the use of 7‐day ECG patch monitors was associated with higher detection of SVT (29.3% vs. 13.8%, p = .042). No serious adverse skin reactions were reported among the ECG patch‐monitored participants.Conclusions: The results suggest that a 7‐day patch‐type continuous ECG monitor is more effective for the detection of supraventricular tachycardia than is a 24‐h Holter monitor. However, the clinical significance of device detected arrhythmia should be consolidated.
- 8 May 2023
- Published by Wiley in Journal of Arrhythmia
- Vol. 39 (3) , 422-429
Open AccessThe efficacy of detecting arrhythmia is higher with 7‐day continuous electrocardiographic patch monitoring than with 24‐h Holter monitoring
Background: Detecting high‐risk arrhythmia is important in diagnosing patients with palpitations. We compared the diagnostic accuracies of 7‐day patch‐type electrocardiographic (ECG) monitoring and 24‐h Holter monitoring for detecting significant arrhythmias in patients with palpitations.Methods: This was a single‐center prospective trial with 58 participants who presented with palpitations, chest pain or syncope. Outcomes were defined as the detection of any one of six arrhythmias, including supraventricular tachycardia (SVT), atrial fibrillation or atrial flutter lasting more than 30 s, pauses of more than 3 s, high‐degree atrioventricular block, ventricular tachycardia (VT) >3 beats, or polymorphic VT/ventricular fibrillation. The McNemar test for paired proportions was used to compare arrhythmia detection rates.Results: The overall arrhythmia detection rate was higher with 7‐day ECG patch monitoring than with 24‐h Holter monitoring (34.5% vs. 19.0%, p = .008). Compared with the use of 24‐h Holter monitors, the use of 7‐day ECG patch monitors was associated with higher detection of SVT (29.3% vs. 13.8%, p = .042). No serious adverse skin reactions were reported among the ECG patch‐monitored participants.Conclusions: The results suggest that a 7‐day patch‐type continuous ECG monitor is more effective for the detection of supraventricular tachycardia than is a 24‐h Holter monitor. However, the clinical significance of device detected arrhythmia should be consolidated.